Výsledky vyhledávání - "FDA Readies New Guidance and User Fee Program for Biosimilars"

FDA Readies New Guidance and User Fee Program for Biosimilars: Drug interchangeability and user fees are contentious issues the FDA must resolve. Is the FDA up to the task?

Autor: Stephen, Barlas

Publikováno v: Biotechnology healthcare. 9(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::61d3dbf161f9b6852914c48a47946a90
https://pubmed.ncbi.nlm.nih.gov/22876212

Zobrazit plný text záznamu